Stocks / NASDAQ / Editas Medicine, Inc.

Editas Medicine, Inc.

Our Opinion

Editas Medicine, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products.

Supporting Evidence:

The company stated in the following press release that they conduct preclinical trials on animals.

Demonstrated efficient editing of hematopoietic stem cells (HSCs) and long-term engraftment and reconstitution of the blood and bone marrow using edited cells in animal models. Read the full article.

Company Description

Editas Medicine, Inc. engages in the development and commercialization of genome editting technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA. [Source: MarketWatch]

Company Website: